|
|
Volumn 120, Issue 2, 2007, Pages
|
|
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS clinical trials group protocol P1021
a
|
|
Author keywords
Agents; AIDS; Antiretroviral; Child; Didanosine; Efavirenz; Emtricitabine; HIV
|
|
Indexed keywords
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
UNCLASSIFIED DRUG;
VIDEX EC;
ABNORMAL LABORATORY RESULT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADOLESCENT;
ADULT;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CREATINE KINASE BLOOD LEVEL;
DEATH;
DRUG CAPSULE;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
GLUCOSE BLOOD LEVEL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MULTICENTER STUDY;
NEUTROPHIL COUNT;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RASH;
SIDE EFFECT;
TREATMENT OUTCOME;
URIC ACID BLOOD LEVEL;
VIRUS LOAD;
ADOLESCENT;
ADULT;
BENZOXAZINES;
CHILD;
CHILD, PRESCHOOL;
CLINICAL PROTOCOLS;
DEOXYCYTIDINE;
DIDANOSINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
TIME;
|
|
EID: 34249302365
PISSN: 00314005
EISSN: 02105721
Source Type: Journal
DOI: 10.1542/peds.2006-0925 Document Type: Article |
|
Times cited : (43)
|
|
References (7)
|
